Carl Zeiss Meditec AG (MEX:AFXN) PE Ratio without NRI: 108.92 (As of Jun. 24, 2026) — 181% Above Median


MEX:AFXN Carl Zeiss Meditec AG MEX:AFXN
68 GF Score
Price MXN3,258.20
GF Value MXN8,900.18
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG PE Ratio without NRI?

Carl Zeiss Meditec AG MEX:AFXN 68 PE Ratio without NRI is 108.92 as of Jun. 24, 2026, which is 181% above its 10-year median of 38.73. GuruFocus rates MEX:AFXN with a GF Score™ of 68/100 and a GF Value™ of MXN8,900.18. The stock has 4 warning signs investors should review. Among 448 Medical Devices & Instruments companies, Carl Zeiss Meditec AG ranks better than 58.71% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-24), Carl Zeiss Meditec AG's share price is MXN3258.20. Carl Zeiss Meditec AG's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was MXN29.89. Therefore, Carl Zeiss Meditec AG's PE Ratio without NRI for today is 108.92.

During the past 13 years, Carl Zeiss Meditec AG's highest PE Ratio without NRI was 94.73. The lowest was 17.18. And the median was 38.73.

Carl Zeiss Meditec AG's EPS without NRI for the three months ended in Dec. 2025 was MXN-1.27. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was MXN29.89.

As of today (2026-06-24), Carl Zeiss Meditec AG's share price is MXN3258.20. Carl Zeiss Meditec AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was MXN29.89. Therefore, Carl Zeiss Meditec AG's PE Ratio (TTM) for today is 108.92.

During the past years, Carl Zeiss Meditec AG's highest PE Ratio (TTM) was 94.73. The lowest was 17.18. And the median was 36.85.

Carl Zeiss Meditec AG's EPS (Diluted) for the three months ended in Dec. 2025 was MXN-1.27. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was MXN29.89.

Carl Zeiss Meditec AG's EPS (Basic) for the three months ended in Dec. 2025 was MXN-1.27. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was MXN29.89.


Carl Zeiss Meditec AG  (MEX:AFXN) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Carl Zeiss Meditec AG PE Ratio without NRI Related Terms


Carl Zeiss Meditec AG PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Carl Zeiss Meditec AG's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG PE Ratio without NRI Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.90 32.66 29.55 38.13 28.43

Carl Zeiss Meditec AG Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.72 34.24 33.33 28.43 29.20

MEX:AFXN vs ISRG, BDX, MDLN: PE Ratio without NRI Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's PE Ratio without NRI falls into.


MEX:AFXN
68GF Score
Carl Zeiss Meditec AG MEX:AFXN
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Carl Zeiss Meditec AG's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=3258.20/29.915
=108.92

Carl Zeiss Meditec AG's Share Price of today is MXN3258.20.
Carl Zeiss Meditec AG's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN29.89.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 108.92 mean?
Carl Zeiss Meditec AG (MEX:AFXN) has a PE Ratio without NRI of 108.92 as of Jun. 24, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Carl Zeiss Meditec AG and its competitors. This is 181% above median its historical median of 38.73. Over the past decade, Carl Zeiss Meditec AG's PE Ratio without NRI has ranged from 17.18 to 94.73. According to the industry distribution chart, Carl Zeiss Meditec AG ranks #185 out of 448 companies in the Medical Devices & Instruments industry, placing it in the top 41.3%.
Is Carl Zeiss Meditec AG's PE Ratio without NRI too high?
Carl Zeiss Meditec AG's current PE Ratio without NRI of 108.92 is 181% above median its 10-year median of 38.73. Over the past 10 years, this metric has ranged from a low of 17.18 to a high of 94.73. The Medical Devices & Instruments industry median PE Ratio without NRI is 23.28. Carl Zeiss Meditec AG's value of 108.92 is 368% above this industry median. Based on the distribution chart, Carl Zeiss Meditec AG ranks #185 out of 448 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Carl Zeiss Meditec AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's PE Ratio without NRI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Carl Zeiss Meditec AG ranks #185 out of 448 companies for PE Ratio without NRI. This puts Carl Zeiss Meditec AG in the upper half of its industry. The industry median PE Ratio without NRI is 23.28. Carl Zeiss Meditec AG's value of 108.92 is 368% above this benchmark. Historically, Carl Zeiss Meditec AG's own PE Ratio without NRI has ranged from 17.18 to 94.73 over the past decade. While the company's 10-year median is 38.73 vs. the industry median of 23.28, Carl Zeiss Meditec AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Medical Devices & Instruments company?
The median PE Ratio without NRI among Medical Devices & Instruments companies is 23.28, based on 448 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carl Zeiss Meditec AG's current PE Ratio without NRI of 108.92 is 368% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Carl Zeiss Meditec AG and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio without NRI is 23.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carl Zeiss Meditec AG's current PE Ratio without NRI is 108.92, which is 181% above median its own 10-year median of 38.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Carl Zeiss Meditec AG (MEX:AFXN) has a current PE Ratio without NRI of 108.92. The stock's GF Value™ is MXN8,900.18, compared to a current price of MXN3,258.20 — trading 63.4% below its estimated fair value. The current PE Ratio without NRI is 108.92, which is 181% above median its 10-year median of 38.73 and 368% above the Medical Devices & Instruments industry median of 23.28. Carl Zeiss Meditec AG's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Carl Zeiss Meditec AG (MEX:AFXN), the current PE Ratio without NRI is 108.92 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carl Zeiss Meditec AG (MEX:AFXN) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of MXN3,258.20 is trading 63.4% below its estimated GF Value™ of MXN8,900.18.

Key valuation signals for MEX:AFXN:

  • PE Ratio without NRI: 108.92 (181% above median its 10-year median of 38.73)
  • GF Value™: MXN8,900.18 vs. price of MXN3,258.20 (63.4% below fair value)
  • GF Score™: 68/100 with 4 warning signs
  • Industry Position: 368% above the Medical Devices & Instruments median (#185 of 448)

No single metric tells the full story. See the MEX:AFXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
68GF Score

Get the complete analysis for MEX:AFXN

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,258.20
Price
MXN8,900.18
GF Value